Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00893048

The Use of Oral Steroids in the Treatment of Cellulitis

Utility of Prednisone in the Treatment of Cellulitis

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The prevalence of cellulitis in society is very high, as much as 3% of visits to Emergency Departments are for the treatment of this disease. The treatment of cellulitis varies depending on the severity. Low severity cases are treated with pain control and antibiotics by mouth and high severity are treated with antibiotics intravenously and pain control. The investigator's hypothesis is to see if the addition of steroids, which are known to decrease inflammation, will decrease the length of the disease process. If so, it will decrease the length of stay if IV antibiotics are needed, it will decrease duration of days out of work and decrease the overall pain control required and therefore patient satisfaction.

Detailed description

The incidence of cellulitis is about 24.6 cases per 1000 person-years, which is an estimate, since cellulitis is not a reportable disease. In some Emergency Departments up to 3% of visits are for cellulitis. Depending on the severity of the disease, some are treated as outpatients, and others are admitted for IV antibiotics. In some Emergency Departments cases of cellulitis are treated in an observation area for 23 hours with doses of IV antibiotics. My proposed research is to see if the addition of one dose of prednisone the treatment will decrease the inflammatory reaction enough to decrease length of stay and treatment and increase patient satisfaction.

Conditions

Interventions

TypeNameDescription
DRUGPrednisonePrednisone, 60 mg, one time at time of diagnosis
DRUGPlacebo Oral TabletPlacebo

Timeline

Start date
2010-01-15
Primary completion
2010-08-31
Completion
2010-08-31
First posted
2009-05-05
Last updated
2017-07-25

Source: ClinicalTrials.gov record NCT00893048. Inclusion in this directory is not an endorsement.